等待开盘 12-19 09:30:00 美东时间
+1.070
+0.85%
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
12-09 10:32
Stifel analyst Steven Wieczynski maintains Wynn Resorts (NASDAQ:WYNN) with a Buy and raises the price target from $150 to $160.
12-08 22:02
Small-cap stocks tracked by the Russell 2000 surged to fresh record highs Thursday as investors piled into the most rate-sensitive corners of the market ahead of next week's widely expected Federal
12-05 02:38
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
11-26 10:07
Shares of travel companies are trading higher ahead of the Thanksgiving holiday...
11-26 00:39
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从6美元升至8美元;HC Wainwright & Co.:维持MediWound"买入"评级,目标价从31美元升至36美元
11-24 11:23
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
11-19 11:01
Wells Fargo analyst Trey Bowers initiates coverage on Wynn Resorts (NASDAQ:WYNN) with a Overweight rating and announces Price Target of $151.
11-18 22:26
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 17:17